News|Articles|March 3, 2005

Nanoparticle Synthesis Process Facilitates Chiral Separations

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Pharma Fundamentals: An Introduction to Hold Times in Biopharmaceuticals

ByRobert Dream,Susan Haigney

July 30th 2026

FDA's Manufacturing Registration Rule's Impact on Advanced Therapies: Part 2

ByJason Bock,Susan Haigney

July 29th 2026

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS) | © Tada Images - stock.adobe.com (521699065)

Seventeen Peptide Guidance Revised: What Developers Need to Know

ByZachary Zubulake

July 29th 2026

GSK to build a new facility at the Cambridge Biomedical Campus

GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy

ByZachary Zubulake

July 28th 2026

FDA's Manufacturing Registration Rule's Impact on Advanced Therapies: Part 1

ByJason Bock

July 28th 2026

Nanoparticle Synthesis Process Facilitates Chiral Separations

Related Content

Pharma Fundamentals: An Introduction to Hold Times in Biopharmaceuticals

FDA's Manufacturing Registration Rule's Impact on Advanced Therapies: Part 2

Seventeen Peptide Guidance Revised: What Developers Need to Know

GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy

FDA's Manufacturing Registration Rule's Impact on Advanced Therapies: Part 1

Trending on Pharmaceutical Technology

Seventeen Peptide Guidance Revised: What Developers Need to Know

GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy

Quality and Regulations eBook July 2026

Pharma Fundamentals: An Introduction to Hold Times in Biopharmaceuticals

Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends